USA - NASDAQ:NCNA - US67022C3043 - ADR
ChartMill assigns a Buy % Consensus number of 83% to NCNA. The Buy consensus is the weighted average rating of the current analysts ratings.
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-09-03 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2024-08-30 | William Blair | Downgrade | Outperform -> Market Perform |
| 2024-08-19 | Oppenheimer | Reiterate | Outperform -> Outperform |
| 2024-07-23 | Oppenheimer | Reiterate | Outperform -> Outperform |
| 2024-07-22 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2024-04-01 | Oppenheimer | Reiterate | Outperform -> Outperform |
| 2023-11-21 | Oppenheimer | Reiterate | Outperform -> Outperform |
| 2023-09-06 | Truist Securities | Reiterate | Buy -> Buy |
| 2023-08-18 | Oppenheimer | Reiterate | Outperform -> Outperform |
| 2023-05-22 | Oppenheimer | Reiterate | Outperform -> Outperform |
| 2022-09-22 | Jefferies | Maintains | Buy |
| 2022-03-03 | Cowen & Co. | Downgrade | Outperform -> Market Perform |
| 2021-11-24 | HC Wainwright & Co. | Maintains | Buy |
The consensus rating for NUCANA PLC-ADR (NCNA) is 82.5 / 100 . This indicates that analysts generally have a positive outlook on the stock.
The number of analysts covering NUCANA PLC-ADR (NCNA) is 8.